Stephanie Y. Wu

Stephanie Wu practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Stephanie Wu's NPI, 1952788184, was assigned on April 27, 2015. Stephanie Wu graduated from Keck School of Medicine of USC in 2015. Stephanie Wu holds California license A144941.

Stephanie Wu's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Stephanie Wu's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Stephanie Wu is also affiliated with USC Arcadia Hospital. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Stephanie Wu to 1 more other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Wu practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Stephanie Wu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Stephanie Wu is board certified in cardiovascular disease by the American Board of Internal Medicine. Stephanie Wu is licensed in California.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT), heart failure, heart valve disorders and high cholesterol among the conditions Stephanie Wu treats.

CMS data shows 2,929 Medicare services from Stephanie Wu across 24 procedure codes in 2024, for 1,566 Medicare patients. Medicare paid $96,432 for them.

CMS counts 1,566 Medicare patients who saw Stephanie Wu in 2024. The largest group is 65 to 74, with 772 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stephanie Wu's median patient age at 68, with 54% women.

In 2024, Stephanie Wu wrote 1,023 Medicare Part D claims for 176 patients. 85% of them were for generic drugs. CMS names the drug for 871 of them, across 19 drugs with 11 or more claims each, at $113,941 in total drug cost. In 2023, CMS named 367 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Stephanie Wu for performance year 2024, reported as part of a group. Stephanie Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stephanie Wu as offering telehealth.

Dmand AI links 5 papers to Stephanie Wu, published from 2017 to 2025. Stephanie Wu's most frequent co-authors are Robert J. Siegel, MD, Vaibhav Agrawal, MD and Ibrahim Taha Aldoss, MD.

CMS Open Payments shows 2 general payments to Stephanie Wu from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $69.

Stephanie Wu graduated from Keck School of Medicine of USC in 2015.

Stephanie Wu is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.